Reading, United Kingdom

Anand Bakle

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anand Bakle: Innovator in Inhalable Drug Formulations

Introduction

Anand Bakle is an innovative inventor based in Reading, GB, known for his contributions to the field of inhalable drug formulations. With a focus on developing new methods for preparing spray-dried particles, his work aims to advance the delivery of pharmaceutical compounds through inhalation.

Latest Patents

Anand Bakle holds a notable patent titled "Inhalable powder formulations of alginate oligomers." This innovative patent describes a method for preparing spray-dried particles intended for inhalation. The process includes providing an aqueous liquid composition with alginate oligomers combined with an anti-adherent compound, alongside an organic liquid composition containing a phospholipid. The method emphasizes creating an organic-in-aqueous liquid emulsion, which is then spray-dried to yield particles suitable for inhalation.

Career Highlights

Anand Bakle has made significant strides in his career as an inventor at Algipharma AS. His approach to inhalable formulations demonstrates a commitment to enhancing drug delivery systems. This advancement not only showcases his technical expertise but also underlines the potential impact of his inventions on patient care and treatment efficacy.

Collaborations

Throughout his career, Anand Bakle has collaborated with talented individuals such as Bildad Nyambura and Arne Dessen. These partnerships contribute to a dynamic work environment at Algipharma AS, fostering innovation and facilitating the development of groundbreaking technologies in inhalable drug formulations.

Conclusion

In conclusion, Anand Bakle represents a remarkable figure in the realm of pharmaceutical innovations. With his patent for inhalable powder formulations and his collaborative approach at Algipharma AS, Bakle continues to make significant contributions to the development of advanced inhalation therapies. His work not only paves the way for future innovations but also enhances the landscape of medical treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…